Blood test picks out cancers likely to benefit from targeted drugs
British researchers discovered that a blood test could identify gastric cancer patients who might benefit from EGFR-inhibiting drugs.
Singapore Clinicians and Scientists Achieve Big Leap in Early Diagnosis of Gastric Cancer Through the Development of Non-Invasive Blood-based Test
Researchers in Singapore have developed a blood test that they believe could be used for early detection of gastric cancer.
UArizona Health Sciences Researchers Find Biomarker that Can Appear Before Stomach Cancer Develops
Researchers at the University of Arizona discovered a biomarker that appears in people before stomach cancer develops and that can be detected... Read More
Blood-Based Test Could Help Identify Hard-to-Detect Gastrointestinal Cancers
A blood test that’s being developed to detect cancer at its earliest stages was roughly 90% effective at detecting gastrointestinal cancers, including... Read More
Novel, high-accuracy blood test can screen for multiple cancers
An investigational blood test for cancer was able to identify early-stage tumors, including gastric cancer, with high accuracy, according to research presented... Read More
Blood test detects more than 20 cancer types
A blood test being developed by Grail was able to detect more than 20 cancer types, including gastric and esophageal cancer, in... Read More
Guardant’s blood test tracks microsatellite instability status on par with tissue biopsy in new study
In a trial involving 949 patients with 40 tumor types, including gastric cancer, a blood test from Guardant Health was as good... Read More